BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 10, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 17, 2010
View Archived Issues
EpiCept's crolibulin enters phase I/II trial in anaplastic thyroid cancer
Read More
Preliminary phase I data presented on TAK-285 in advanced cancer
Read More
ABT-806 enters phase I trial in EGFR-expressing advanced solid tumors
Read More
Serodus licenses RO-1160367 from Roche
Read More
Trophos to lead MitoCare consortium to study cardioprotective agent TRO-40303
Read More
Ocera Therapeutics completes two studies of OCR-002
Read More
AstraZeneca divulges novel ligands of androgen receptor
Read More
New HIV integrase inhibitors discovered at Boehringer Ingelheim
Read More
ACY-1215/bortezomib combination shows promise in models of multiple myeloma
Read More
Preclinical study in MM shows activity of GNE-652 and synergism with GDC-0941
Read More
Selective JAK-2 inhibitor BMS-911543 enters clinic as myelofibrosis therapy
Read More
Tivozanib/paclitaxel combination is well tolerated by patients with metastatic breast cancer
Read More
Xention's new company Provesica to handle OAB program
Read More
Lundbeck, Zenobia and Vernalis to codevelop dardarin inhibitors
Read More
Ipsen discontinues development of BIM-23A760
Read More
New diaza heterocyclic agents identified at Mallinckrodt
Read More
Adimab to collaborate with Lilly, Genentech and Human Genome Sciences
Read More
E.C. approves sunitinib malate for treatment of pancreatic neuroendocrine tumors
Read More
Novartis withdraws application to extend Zometa indication in E.U.
Read More
Palau Pharma begins phase II trial of UR-63325 for allergic respiratory diseases
Read More
Concert Pharma patents new PEGylated azapeptide derivatives
Read More
Amgen identifies novel inhibitors of PI3K-alpha and/or mTOR
Read More
SciClone stops development of SCV-07 in chronic HCV infection based on phase IIb data
Read More
Provectus begins phase IIc trial of PH-10 in psoriasis
Read More
Jennerex and Transgene begin JX-594 trial in metastatic colorectal cancer
Read More
